Ed Ho
Member since: Dec '00
Portfolio Manager at
Dynamic Mutual Funds

Latest Top Picks

Not really happy with management. Took a big drop and is an interesting buy now. The drug works. Potential of being in phase three next year. Really cheap.
Biotech world has had a tough time in the last month. This company is progressing well. Will take over the clinical development which is very lucrative for the company. Likes management and their pipeline.
Have about $11/12 million in cash and $23/24 million in sales. Profitable. Trading at half X sales. Cheap. Good management.
Have put in new (better) management and have recapitalized the costs.
Disappointed on their 2nd quarter, but they were building and shipping inventory in the first two quarters so results won't show until the 3rd/4th quarters.